North America Superdisintegrants Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
to 2027 - Regional Analysis and Forecasts by Type (Synthetic Superdisintegrants, Natural Superdisintegrants, Other Superdisintegrants); Formulation (Tablets, Capsules); Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, Inflammatory Diseases, Infectious Diseases, Cardiovascular Diseases, Other Diseases), and Country

No. of Pages: 167    |    Report Code: TIPRE00009244    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Superdisintegrants Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Superdisintegrants Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Superdisintegrants Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 An increase in Demand for Superdisintegrants leads to the Growing Adoption of Orally Disintegrating Drugs
5.2 Market Opportunities
  • 5.2.1 Significant Research and Development to Develop Pharmaceutical Products
5.3 Future Trends
  • 5.3.1 The Increasing Acceptability of Generic Drugs
5.4 Impact of Drivers and Restraints

6. North America Superdisintegrants Market Regional Analysis

6.1 North America Superdisintegrants Market Overview
6.2 North America Superdisintegrants Market Revenue 2017-2027 (US$ Million)
6.3 North America Superdisintegrants Market Forecast Analysis

7. North America Superdisintegrants Market Analysis – by Type

7.1 Synthetic Superdisintegrants
  • 7.1.1 Overview
  • 7.1.2 Synthetic Superdisintegrants: North America Superdisintegrants Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Natural Superdisintegrants
  • 7.2.1 Overview
  • 7.2.2 Natural Superdisintegrants: North America Superdisintegrants Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Other Superdisintegrants
  • 7.3.1 Overview
  • 7.3.2 Other Superdisintegrants: North America Superdisintegrants Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Superdisintegrants Market Analysis – by Formulation

8.1 Tablets
  • 8.1.1 Overview
  • 8.1.2 Tablets: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Capsules
  • 8.2.1 Overview
  • 8.2.2 Capsules: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Superdisintegrants Market Analysis – by Therapeutic Area

9.1 Neurological Diseases
  • 9.1.1 Overview
  • 9.1.2 Capsules: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Gastrointestinal Diseases
  • 9.2.1 Overview
  • 9.2.2 Capsules: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Oncology
  • 9.3.1 Overview
  • 9.3.2 Capsules: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Inflammatory Diseases
  • 9.4.1 Overview
  • 9.4.2 Capsules: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Infectious Diseases
  • 9.5.1 Overview
  • 9.5.2 Capsules: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Cardiovascular Diseases
  • 9.6.1 Overview
  • 9.6.2 Capsules: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Other Diseases
  • 9.7.1 Overview
  • 9.7.2 Capsules: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Superdisintegrants Market – North America Analysis

10.1 North America
  • 10.1.1 North America Superdisintegrants Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 North America Superdisintegrants Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 US: North America Superdisintegrants Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Superdisintegrants Market Breakdown, by Formulation
    • 10.1.1.1.3 US: North America Superdisintegrants Market Breakdown, by Therapeutic Area
  • 10.1.1.2 Canada: North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Canada: North America Superdisintegrants Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Superdisintegrants Market Breakdown, by Formulation
    • 10.1.1.2.3 Canada: North America Superdisintegrants Market Breakdown, by Therapeutic Area
  • 10.1.1.3 Mexico : North America Superdisintegrants Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Superdisintegrants Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America Superdisintegrants Market Breakdown, by Formulation
    • 10.1.1.3.3 Mexico : North America Superdisintegrants Market Breakdown, by Therapeutic Area

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Superdisintegrants Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Ashland,
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BASF SE
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 DowDupont Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 JRS PHARMA
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 COREL PHARMA CHEM
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Roquette Frères
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Asahi Kasei Corporation
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Merck KGaA
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Avantor, Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 DFE Pharma
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

The List of Companies - North America Superdisintegrants Market

  1. Ashland,
  2. BASF SE
  3. DowDupont Inc.
  4. JRS PHARMA
  5. COREL PHARMA CHEM
  6. Roquette Frères
  7. Asahi Kasei Corporation
  8. Merck KGaA
  9. Avantor, Inc.
  10. DFE Pharma

 

north-america-superdisintegrantsmarket